Please login to the form below
Patient pathways
This page shows the latest Patient pathways news and features for those working in and with pharma, biotech and healthcare.
No patient left behind
Tailoring the solution. We need to understand that patient pathways are not always the same, especially for those with rare diseases. ... The patient’s perspective. With rare diseases, the patient often becomes the expert in their condition.
Latest news
-
J&J bags FDA breakthrough designation for prostate cancer drug
Either way, the emergence of these new PARP inhibitors holds a particular significance in prostate cancer, holding the promise of unlocking new targeted treatment pathways for a select patient population.
-
Sage gets final US clearance for postpartum depression drug Zulresso
Sage is taking on those challenges and creating a family-centric approach to Zulresso availability by enabling pathways to care including building our patient support organisation, where we will provide a
-
Power to the people
drug design, care pathways and patient journeys. ... a highly regulated industry where it’s difficult to even talk to a patient.
-
EMA develops framework for academia collaborations
It will also help academic start-ups benefit from advice from the EU regulatory network to translate their discoveries into patient-focus medicines.”. ... The agency has also created a new section on its website to provide information for academia,
-
Takeda pilots Apple Watch depression app
assist healthcare professionals in creating improved patient care pathways.”. ... Healthcare professionals can obtain patient data and increase patient engagement in their treatment.”.
More from news
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest Intelligence
-
How understanding the rare disease patient’s lived experience creates better health communications
Research has found that the average rare disease patient consults five doctors and waits four years before receiving a final diagnosis. ... Understanding the lived experience – a real life example. Successful healthcare communication within rare
-
Making the case for embedding personalised healthcare in secondary care – what can pharma do to help?
care patient pathways initiated in secondary care. ... If we take multiple sclerosis (MS) as a living example, we know that patient outcomes are better when patients have a key role to play in their ongoing treatment.
-
Mapping patient pathways – with a focus on patient-centricity
By Alison Dunlop. As the patient experience is increasingly recognised as a critical factor in achieving better outcomes, placing the patient perspective at the heart of designing inclusive patient pathways is ... As healthcare professionals (HCPs) look
-
Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity
Using the patient profile and the treatment pathway enables the development of customised digital recruitment outreach for the entire study. ... Additional country-specific programmes may also need to be developed and executed to support more local
-
Harnessing the power of patient intelligence can redefine your success
Patient pathways and patient journey maps. Patient pathways and patient journey maps play a key role in helping a pharmaceutical team understand the patient treatment ecosystem. ... Some of the patient pathways and journey maps currently be used in our
More from intelligence
Approximately 1 fully matching, plus 32 partially matching documents found.
Latest appointments
-
Ashfield appoints new UK head of patient solutions
She has also worked with many key opinion leaders (KOLs) and facilitated advisory boards to aid the delivery of new models of patient care pathways, and was the winner of the ... Following our investment in Salesforce Health Cloud, our Patient Solutions
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Patient centricity in pharma: musings of a doctor turned medical writer
We work to improve that patient’s life – its quality and perhaps also its quantity. ... These more personalised ways of working within the industry could help engender patient centricity in treatment pathways and make it a regular, integral part of
-
Understanding the role of provider collaboratives
What are some of the likely impacts on care pathways? Place-based care models will also give rise to innovation and change within services. ... These developments will have wide-ranging impact on pharma, from new customers and payers, to changes in
-
Integrated NHS finances: what do they mean for High Cost Drugs?
This was later followed by the introduction of system-level funding. which together with other joined-up finance structures already in place, will drive big changes in patient pathways. ... bring opportunities to support providers by identifying ways to
-
How has the pandemic reshaped the NHS in 2020?
Patient safety, with regard to how a particular drug fits into the new Covid-friendly pathways, continues to be a critical factor for immunocompromised patients and this has been having a ... changes that are now occurring across patient pathways.
-
Harness the power of data to map new patient pathways
Introduction. To capitalise on innovations and continue to drive improvements, as part of the Reset, the NHS needs to understand how new patient pathways are performing and how covid-19 is ... Key data that can be gathered includes patient flows and
More from PMHub
Approximately 0 fully matching, plus 27 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
